Cytomegalovirus Diagnostics Market Research Insights, Trends Forecast 2022-28

The global cytomegalovirus diagnostics market size was valued at USD 73.6 million in 2021, growing at a CAGR of 6.1% during the forecast period 2022-28. A common herpesvirus called cytomegalovirus can produce a wide range of symptoms, from little to no symptoms to fever and tiredness to severe symptoms affecting the brain, eyes, and other internal organs. Plasma, sperm, saliva, urinalysis, and breast milk can all be used as transmission routes for the dangerous disease CMV. Antiviral medication is the most frequently used kind of treatment. They cannot stop the virus from reproducing, but they can slow it down. To treat cytomegalovirus, ganciclovir, foscarnet, valganciclovir, cidofovir, and other antiviral drugs are offered on the market.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-cytomegalovirus-diagnostics-market/

The Cytomegalovirus Diagnostics Market Growth Factors:
One of the main factors influencing the market's rate of growth during the predicted period is the rising prevalence of CMV infection. In accordance with the Centers for Disease Control and Prevention, one in every 150 infants in the US is born with congenital cytomegalovirus (CMV) infection (CDC). Only one in five new-borns who develop CMV go on to have long-term health problems. Due to increased infection rates and the need for better treatment options, the market for CMV infection treatment and diagnosis will grow. Additionally, the market for CMV will grow because of people's sedentary lifestyles and the increasing number of government campaigns to raise awareness. Along with this, growing healthcare costs and patent expirations that result in the availability of generic pharmaceuticals will accelerate the market's growth pace. Additionally, it is predicted that an increase in organ transplantation around the globe will accelerate market growth.

The Cytomegalovirus Diagnostics Market Segmentation:
The global cytomegalovirus diagnostics market on the basis of Test, market is segregated into Serology, Cell culture, Antigenemia assay, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic acid sequence-based amplification (NASBA), and Hybrid capture assay). Based on Application, the market is categorized into Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, and Others. Based on End-user, the market is divided into Hospitals, Diagnostic Centers, and Others.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16046

The Cytomegalovirus Diagnostics Market Regional Analysis:
Geographically, the market for CMV diagnostics is dominated by North America, led by the European market. The region's established healthcare infrastructure, together with its residents' high levels of awareness and access to affordable disease diagnosis and treatment, are some of the key drivers behind the market's expansion in the area.

Key players' profiles in the cytomegalovirus diagnostics market report are Cell Medical Ltd. (U.K.), Merck & Co. Inc. (U.S.), Chimerix, Inc. (U.S.), Abbott Laboratories (U.S.), Affymetrix, Inc. (U.S.), Becton, Dickinson and Company (U.S.)

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.